Impact of Medicare Part D Opioid Safety Policies on Disabled Beneficiaries Before and During the COVID-19 Pandemic

The project seeks to inform policymakers about the implications of the 2019 Medicare Part D safety policy for an understudied, high-risk population of disabled beneficiaries who are prescribed long-term, high-dose opioid therapy, which will further enable policymakers to develop clinically and culturally nuanced policies and practices tailored to the disabled population, the racial/ethnic minority patients and rural patients, and the evolving pandemic/post-pandemic environment.